MPH, Clinical and Public Health Researcher, Cardiac Implants LLCNew York University, New York, USA
Dr. Nodar Kipshidze is an Clinical scientist and epidemiologist with over six years of experience in designing and executing complex clinical trials and studies. Proven track record with over 20 peer-reviewed publications. Infectious disease research experience in Dengue Virus, Ebola, HIV/AIDS, SARS-CoV2/COVID-19, and Zika Virus. Non-communicable disease experiences in cardiovascular diseases, obesity, and oncology.
Prospective
Targeted Site-Specific Therapeutics for COVID-19
Author(s): Iversen P, Porter TR and Kipshidze N*
No definitive therapies for COVID-19 have yet to be identified. The several hundred planned or ongoing clinical trials globally will provide some insights into therapies that may or may not work. The overwhelming majority of therapeutics relies on the systemic delivery of drugs; however, COVID-19 is largely localized to the lungs with some subgroups afflicted in other organ systems. We propose the use of a targeted drug delivery approach in which therapeutics can be delivered using engineered delivery vehicles to reach damaged lung tissue directly. .. View more»